Epilepsy Foundation Honors The Medtronic Foundation For Putting People First
The Epilepsy Foundation honored the Medtronic Foundation for its ongoing dedication and determination to helping people with chronic neurological conditions. The award was presented by the Epilepsy Foundation's president and CEO, Eric R. Hargis, during a ceremony at Medtronic's world headquarters in Fridley, Minn.
Failure To Take Seizure Drugs Linked To Increased Risk Of Death
People with epilepsy who fail to take their seizure medication regularly could be as much as three times more likely to die, according to a study published in the June 18, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology.
Gene Mutation In Rare Form Of Epilepsy
Scientists have identified a genetic mutation responsible for a rare condition called epilepsy and mental retardation limited to females (EFMR), The Times reports. As the name suggests, this condition only affects females and causes seizures that start in infancy or early childhood, as well as cognitive impairment.
First EMEA Licensed Treatment Specifically For LGS Offers New Hope For Patients With Epilepsy
Eisai Europe Limited, (Headquarters: London, Chairman and CEO Yutaka Tsuchiya) today announced publication of the results of a major study of its new anti-epileptic agent Inovelon (rufinamide) indicated for adjunctive therapy in Lennox-Gastaut Syndrome (LGS), a severe form of generalised epilepsy that develops in early childhood.
Diabetes Drug May Hold Potential As Treatment For Epilepsy, Using Same Mechanism As Ketogenic Diet
Two years ago, University of Wisconsin-Madison scientists reported they had suppressed epileptic seizures in rats by giving them a glycolytic-inhibitor, inhibiting the brain's ability to turn sugar into excess energy and blocking the expression of seizure-related genes.
Randomised Trial Confirms Efficacy Of Ketogenic Diet In Preventing Epileptic Seizures In Children
A randomised controlled trial has confirmed the efficacy of the ketogenic diet in helping control and prevent epileptic seizures in children with drug-resistant epilepsy. These are the conclusions of authors of an Article published early Online and in the June edition of The Lancet Neurology.
Mutant Gene Causes Epilepsy, Intellectual Disability In Women
A mutated gene has been discovered as the key behind epilepsy and mental retardation specific to women, thanks to new research at Adelaide's Women's & Children's Hospital and the University of Adelaide, Australia.The world-first discovery, published in Nature Genetics, shows that although men carry the 'bad' gene, only women are affected.
Data Show Rufinamide, An Investigational Adjunctive Treatment For Lennox- Gastaut Syndrome, Reduced Drop Attacks By More Than 40
Eisai Corporation of North America announced the publication of a placebo-controlled study in Neurology that found patients with Lennox-Gastaut syndrome (LGS) treated with the investigational antiepileptic agent rufinamide as adjunctive therapy experienced more than 40% fewer drop attacks than patients who received placebo (increase of 1.
Diabetes Drug May Hold Potential As Treatment For Epilepsy
Metformine, a widely used diabetic drug, might also be an effective and safe therapy for epilepsy, researchers report. This new approach may be especially helpful for the subset of patients who have recurrent seizures despite therapy with the best available drugs.
Data Presented At AAN Support Potential For Adjunctive Use Of Intravenous Lacosamide As Short-Term Replacement For Oral Treatment In Partial Epilepsy
Data presented at a platform session of the 60th Annual Meeting of the American Academy of Neurology (AAN) in Chicago support the potential for adjunctive use of intravenous lacosamide 200-600 mg/day using infusion durations as fast as 10 minutes for short term replacement of oral lacosamide in adult patients with partial onset seizures.